- Home
- AVBC vs CATX Comparison
AVBC vs CATX Comparison
Compare AVBC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.13
Company Overview
Basic Information| Metric | AVBC | CATX |
|---|---|---|
| Founded | 1869 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.8M | 341.0M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AVBC | CATX |
|---|---|---|
| Price | $22.07 | $3.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $18.00 | $12.11 |
| AVG Volume (30 Days) | 113.2K | ★ 1.1M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $69.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.31 | $1.96 |
| 52 Week High | $22.90 | $6.16 |
Technical Indicators
Market Signals| Indicator | AVBC | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 52.16 |
| Support Level | $19.67 | $2.82 |
| Resistance Level | $22.90 | $4.27 |
| Average True Range (ATR) | 0.65 | 0.17 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 60.10 | 72.03 |
Price Performance
Historical Comparison AVBC
CATX
About AVBC Avidia Bancorp Inc.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.